Published in Arterioscler Thromb Vasc Biol on November 10, 2011
Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding. J Exp Med (2014) 1.80
A talin mutant that impairs talin-integrin binding in platelets decelerates αIIbβ3 activation without pathological bleeding. Blood (2014) 1.55
Rho GTPases in platelet function. J Thromb Haemost (2013) 1.15
Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev (2014) 1.07
Emerging roles of store-operated Ca²⁺ entry through STIM and ORAI proteins in immunity, hemostasis and cancer. Channels (Austin) (2013) 1.00
RASA3 is a critical inhibitor of RAP1-dependent platelet activation. J Clin Invest (2015) 0.99
Platelets in inflammation and atherogenesis. Front Immunol (2015) 0.94
Platelet mechanosensing of substrate stiffness during clot formation mediates adhesion, spreading, and activation. Proc Natl Acad Sci U S A (2014) 0.93
Secrets of platelet exocytosis - what do we really know about platelet secretion mechanisms? Br J Haematol (2013) 0.90
Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity. Circ Res (2014) 0.87
The Small GTPase Rap1b: A Bidirectional Regulator of Platelet Adhesion Receptors. J Signal Transduct (2012) 0.83
CalDAG-GEFI deficiency protects mice from FcγRIIa-mediated thrombotic thrombocytopenia induced by CD40L and β2GPI immune complexes. J Thromb Haemost (2014) 0.81
Platelet signaling: a complex interplay between inhibitory and activatory networks. J Thromb Haemost (2016) 0.81
RAP1-GTPase signaling and platelet function. J Mol Med (Berl) (2015) 0.81
EHT 1864, a small molecule inhibitor of Ras-related C3 botulinum toxin substrate 1 (Rac1), attenuates glucose-stimulated insulin secretion in pancreatic β-cells. Cell Signal (2015) 0.78
The Phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3)-binder Rasa3 Regulates Phosphoinositide 3-kinase (PI 3-kinase)-dependent Integrin αIIbβ3 Outside-in Signaling. J Biol Chem (2016) 0.75
The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell (1992) 30.02
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell (1992) 28.36
Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell (1995) 24.99
Rho GTPases and their effector proteins. Biochem J (2000) 8.89
GEFs and GAPs: critical elements in the control of small G proteins. Cell (2007) 7.32
Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci U S A (2004) 7.24
Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature (2001) 5.51
Ras and Rho GTPases: a family reunion. Cell (2000) 4.21
Regulatory and signaling properties of the Vav family. Mol Cell Biol (2000) 3.14
CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med (2004) 3.03
A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proc Natl Acad Sci U S A (1998) 2.47
Rap1b is required for normal platelet function and hemostasis in mice. J Clin Invest (2005) 2.46
Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol (2010) 2.43
Rap1 promotes cell spreading by localizing Rac guanine nucleotide exchange factors. J Cell Biol (2004) 2.27
Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases. J Biol Chem (2007) 2.20
Rac1 is essential for platelet lamellipodia formation and aggregate stability under flow. J Biol Chem (2005) 2.07
P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest (2003) 1.90
Specificity in Ras and Rap signaling. J Biol Chem (2008) 1.62
Flow cytometric detection of activated mouse integrin alphaIIbbeta3 with a novel monoclonal antibody. Cytometry (2002) 1.62
Dynamics of the Rho-family small GTPases in actin regulation and motility. Cell Adh Migr (2011) 1.60
Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway. Blood (2008) 1.47
CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets. Blood (2008) 1.41
Vav1 and vav3 have critical but redundant roles in mediating platelet activation by collagen. J Biol Chem (2004) 1.40
The kinetics of αIIbβ3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy. Blood (2010) 1.40
Activation of Rap1B by G(i) family members in platelets. J Biol Chem (2002) 1.39
The Par polarity complex regulates Rap1- and chemokine-induced T cell polarization. J Cell Biol (2007) 1.38
CalDAG-GEFI is at the nexus of calcium-dependent platelet activation. Blood (2009) 1.33
A Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets. J Biol Chem (2002) 1.21
Differential regulation of Rho and Rac through heterotrimeric G-proteins and cyclic nucleotides. J Biol Chem (2001) 1.19
RAC1 inhibition targets amyloid precursor protein processing by gamma-secretase and decreases Abeta production in vitro and in vivo. J Biol Chem (2005) 1.17
Association of rap1 and rap2 proteins with the specific granules of human neutrophils. Translocation to the plasma membrane during cell activation. J Biol Chem (1992) 1.15
Structure and function of rap proteins in human platelets. Thromb Haemost (1994) 1.14
Genetic and pharmacologic evidence that Rac1 GTPase is involved in regulation of platelet secretion and aggregation. J Thromb Haemost (2007) 1.12
Phosphorylation of CLEC-2 is dependent on lipid rafts, actin polymerization, secondary mediators, and Rac. Blood (2010) 1.11
Rap1, a mercenary among the Ras-like GTPases. Dev Biol (2010) 1.10
Rac1 is essential for phospholipase C-gamma2 activation in platelets. Pflugers Arch (2008) 1.08
Rho GTPases and exocytosis: what are the molecular links? Semin Cell Dev Biol (2010) 1.06
Isozyme-specific stimulation of phospholipase C-gamma2 by Rac GTPases. J Biol Chem (2005) 1.05
Unraveling a novel Rac1-mediated signaling pathway that regulates cofilin dephosphorylation and secretion in thrombin-stimulated platelets. Blood (2009) 1.04
The P2Y12 antagonists, 2-methylthioadenosine 5'-monophosphate triethylammonium salt and cangrelor (ARC69931MX), can inhibit human platelet aggregation through a Gi-independent increase in cAMP levels. J Biol Chem (2009) 1.03
Characterisation of Rac activation in thrombin- and collagen-stimulated human blood platelets. FEBS Lett (2001) 1.02
Role of intracellular signaling events in ADP-induced platelet aggregation. Thromb Haemost (1999) 1.02
Distinct roles for Rap1b protein in platelet secretion and integrin αIIbβ3 outside-in signaling. J Biol Chem (2011) 1.01
Sequential activation of Rap1 and Rac1 small G proteins by PDGF locally at leading edges of NIH3T3 cells. Genes Cells (2008) 1.00
Small G proteins as key regulators of pancreatic digestive enzyme secretion. Am J Physiol Endocrinol Metab (2008) 0.94
Beta-adrenergic-induced cytosolic redistribution of Rap1 in rat parotid acini: role in secretion. Am J Physiol (1998) 0.92
cAMP is not an important messenger for ADP-induced platelet aggregation. Blood Coagul Fibrinolysis (1996) 0.88
Inhibition and reversal of platelet activation by cytochalasin B or colcemid. Nature (1973) 0.87
Epac signaling pathway involves STEF, a guanine nucleotide exchange factor for Rac, to regulate APP processing. FEBS Lett (2007) 0.85
Integrin alpha2beta1 induces phosphorylation-dependent and phosphorylation-independent activation of phospholipase Cgamma2 in platelets: role of Src kinase and Rac GTPase. J Thromb Haemost (2009) 0.84
Wnt signalling regulates adult hippocampal neurogenesis. Nature (2005) 6.66
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity. N Engl J Med (2015) 4.50
CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med (2004) 3.03
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nat Med (2013) 2.84
A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med (2002) 2.75
The clearance mechanism of chilled blood platelets. Cell (2003) 2.25
Systemic antithrombotic effects of ADAMTS13. J Exp Med (2006) 2.21
Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases. J Biol Chem (2007) 2.20
Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1. J Biol Chem (2005) 2.09
P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest (2003) 1.90
Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc Natl Acad Sci U S A (2007) 1.83
Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in mice. Blood (2011) 1.83
Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood (2014) 1.81
Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin. Blood (2005) 1.78
p38 mitogen-activated protein kinase activation during platelet storage: consequences for platelet recovery and hemostatic function in vivo. Blood (2009) 1.71
Leukocyte engagement of platelet glycoprotein Ibalpha via the integrin Mac-1 is critical for the biological response to vascular injury. Circulation (2005) 1.69
PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model. Blood (2010) 1.61
Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity. Arterioscler Thromb Vasc Biol (2011) 1.56
A talin mutant that impairs talin-integrin binding in platelets decelerates αIIbβ3 activation without pathological bleeding. Blood (2014) 1.55
Protein kinase Calpha phosphorylates the TRPC1 channel and regulates store-operated Ca2+ entry in endothelial cells. J Biol Chem (2004) 1.53
Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci Signal (2010) 1.52
Regulation of platelet granule exocytosis by S-nitrosylation. Proc Natl Acad Sci U S A (2005) 1.52
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling. J Clin Invest (2012) 1.45
von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins. Blood (2006) 1.44
RhoA interaction with inositol 1,4,5-trisphosphate receptor and transient receptor potential channel-1 regulates Ca2+ entry. Role in signaling increased endothelial permeability. J Biol Chem (2003) 1.43
Mechanisms and implications of platelet discoid shape. Blood (2003) 1.42
CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets. Blood (2008) 1.41
The kinetics of αIIbβ3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy. Blood (2010) 1.40
Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding. Proc Natl Acad Sci U S A (2003) 1.38
Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc Natl Acad Sci U S A (2003) 1.36
Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation. J Biol Chem (2005) 1.34
Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c. Nat Med (2013) 1.34
CalDAG-GEFI is at the nexus of calcium-dependent platelet activation. Blood (2009) 1.33
Complementary roles of glycoprotein VI and alpha2beta1 integrin in collagen-induced thrombus formation in flowing whole blood ex vivo. FASEB J (2003) 1.28
Distinct clathrin-coated pits sort different G protein-coupled receptor cargo. Traffic (2006) 1.28
P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. Blood (2005) 1.26
Antithrombotic activity of TNF-alpha. J Clin Invest (2003) 1.25
2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity. J Med Chem (2006) 1.25
Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest (2013) 1.24
Rap1a activation by CalDAG-GEFI and p38 MAPK is involved in E-selectin-dependent slow leukocyte rolling. Eur J Immunol (2011) 1.19
Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling. Blood (2005) 1.18
RAC1 inhibition targets amyloid precursor protein processing by gamma-secretase and decreases Abeta production in vitro and in vivo. J Biol Chem (2005) 1.17
CalDAG-GEFI deficiency protects mice in a novel model of Fcγ RIIA-mediated thrombosis and thrombocytopenia. Blood (2011) 1.15
PAR1, but not PAR4, activates human platelets through a Gi/o/phosphoinositide-3 kinase signaling axis. Mol Pharmacol (2007) 1.13
Modulatory role of focal adhesion kinase in regulating human pulmonary arterial endothelial barrier function. J Physiol (2002) 1.13
Role of syndecan-1 in leukocyte-endothelial interactions in the ocular vasculature. Invest Ophthalmol Vis Sci (2002) 1.11
Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial. Circ Cardiovasc Interv (2012) 1.11
Phosphorylation of CLEC-2 is dependent on lipid rafts, actin polymerization, secondary mediators, and Rac. Blood (2010) 1.11
G-protein-coupled receptors as signaling targets for antiplatelet therapy. Arterioscler Thromb Vasc Biol (2008) 1.10
Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets. Blood (2002) 1.08
Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol (2008) 1.08
Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis. Circulation (2003) 1.08
Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovasc Res (2009) 1.06
Platelet-derived S100 family member myeloid-related protein-14 regulates thrombosis. J Clin Invest (2014) 1.06
Interaural level difference processing in the lateral superior olive and the inferior colliculus. J Neurophysiol (2004) 1.06
Distinct roles for protein kinase C isoforms in regulating platelet purinergic receptor function. Mol Pharmacol (2006) 1.04
Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase. J Med Chem (2011) 1.03
Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow. Blood (2010) 1.00
RASA3 is a critical inhibitor of RAP1-dependent platelet activation. J Clin Invest (2015) 0.99
A direct role for C1 inhibitor in regulation of leukocyte adhesion. J Immunol (2005) 0.98
In vitro function and phagocytosis of galactosylated platelet concentrates after long-term refrigeration. Transfusion (2007) 0.96
Inhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer. Endocr Relat Cancer (2011) 0.95
Newer agents in antiplatelet therapy: a review. J Blood Med (2012) 0.94
Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing. J Neurochem (2008) 0.94
PSGL-1 regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets. Thromb Haemost (2007) 0.93
12-lipoxygenase: a potential target for novel anti-platelet therapeutics. Cardiovasc Hematol Agents Med Chem (2011) 0.92
In vitro and in vivo antiangiogenic properties of the serpin protease nexin-1. Mol Cell Biol (2012) 0.92
Protein kinase C regulation of 12-lipoxygenase-mediated human platelet activation. Mol Pharmacol (2011) 0.92
Investigations of human platelet-type 12-lipoxygenase: role of lipoxygenase products in platelet activation. J Lipid Res (2012) 0.91
Flow-cytometric analysis of mouse platelet function. Methods Mol Biol (2004) 0.91
Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-O-sulfamates. J Steroid Biochem Mol Biol (2005) 0.90
Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase. J Med Chem (2014) 0.89
The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease. Curr Opin Hematol (2003) 0.88
Cutting edge: Leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor. J Immunol (2013) 0.88
Role of the P2Y12 receptor in the modulation of murine dendritic cell function by ADP. J Immunol (2010) 0.87
Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity. Circ Res (2014) 0.87
Macrophages and platelets are the major source of protease nexin-1 in human atherosclerotic plaque. Arterioscler Thromb Vasc Biol (2008) 0.87
Role of protein kinase Czeta in thrombin-induced RhoA activation and inter-endothelial gap formation of human dermal microvessel endothelial cell monolayers. Microvasc Res (2010) 0.87
Emerging role of serpinE2/protease nexin-1 in hemostasis and vascular biology. Blood (2012) 0.87
CalDAG-GEFI and platelet activation. Platelets (2010) 0.86
The Src family kinases and protein kinase C synergize to mediate Gq-dependent platelet activation. J Biol Chem (2012) 0.85
Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease. J Alzheimers Dis (2012) 0.84
Development of a perfusion chamber assay to study in real time the kinetics of thrombosis and the antithrombotic characteristics of antiplatelet drugs. Thromb J (2012) 0.84
Targeting of platelet integrin alphaIIbbeta3 determines systemic reaction and bleeding in murine thrombocytopenia regulated by activating and inhibitory FcgammaR. Int Immunol (2003) 0.83
Aspirin induces platelet receptor shedding via ADAM17 (TACE). J Biol Chem (2005) 0.82
Thienopyridines, but not elinogrel, result in off-target effects at the vessel wall that contribute to bleeding. J Pharmacol Exp Ther (2011) 0.81
Human genome-wide association and mouse knockout approaches identify platelet supervillin as an inhibitor of thrombus formation under shear stress. Circulation (2012) 0.81
Structure-activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding. Bioorg Med Chem Lett (2009) 0.81
Mechanisms of interferon-γ production by neutrophils and its function during Streptococcus pneumoniae pneumonia. Am J Respir Cell Mol Biol (2015) 0.80
Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors. Bioorg Med Chem (2012) 0.80
A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist. J Pharmacol Exp Ther (2011) 0.79